中国药物评价Issue(1)：17-20,4.
微小RNA在肝癌分子靶向治疗中的作用及研究进展
Research Progress of MicoRNA in Molecular Targeting Treatment of Hepatocellular Carcinoma
摘要
Abstract
MicroRNAs ( miRs) ,small non-coding single-stranded RNAs of 18~25 nucleotides in length, play a critical role in the in-itiation,progression and metastasis of hepatocellular carcinoma ( HCC).In recent years,many kinds of miRNA regulators were discovered, and were confirmed effective in the treatment of various malignancy.These prompt that miRs could become new targets of molecular targe-ting treatment in HCC.This review focuses on new progress in miRs which play an important role in molecular targeting treatment of HCC.关键词
微小RNA/肝癌/微小RNA调节剂/分子靶向治疗Key words
miRNA/Hepatocellular/Carcinoma/miRNA regulator/Molecular targeted therapy分类
医药卫生引用本文复制引用
邓丹凤,裘云庆..微小RNA在肝癌分子靶向治疗中的作用及研究进展[J].中国药物评价,2015,(1):17-20,4.基金项目
浙江省科技厅国际合作重大专项“国家一类肝癌治疗药 BZG-4000的作用机理和药效学研究” （）
